Drug Discovery • Biomarkers • Neuroscience • Molecular Biology • Translational Medicine • Life Sciences • Clinical Development • Pharmaceutical Industry • Pharmacology • Assay Development • Immunology • In Vitro • Science • Cell • Protein Chemistry • Clinical Research • In Vivo • Elisa • Metabolism • Translational Pharmaceutical Research • High Throughput Screening • Lifesciences • Bio Molecular Screening
Abbvie Sep 2010 - Jul 2014
Senior Scientist Ii
Abbvie Sep 2010 - Jul 2014
Senior Scientist Ii Toxicology
Abbott Jan 2005 - Sep 2010
Senior Scientist
Abbott Jun 2002 - Feb 2005
Scientist
Education:
Louisiana State University Jan 1, 1991 - 1993
Master of Science, Masters
Alma College Jan 1, 1987 - Dec 31, 1991
Bachelors, Bachelor of Science, Biology
Skills:
Drug Discovery Biomarkers Neuroscience Molecular Biology Translational Medicine Life Sciences Clinical Development Pharmaceutical Industry Pharmacology Assay Development Immunology In Vitro Science Cell Protein Chemistry Clinical Research In Vivo Elisa Metabolism Translational Pharmaceutical Research High Throughput Screening Lifesciences Bio Molecular Screening
Mark Matulenko - Libertyville IL, US Tammie Jinkerson - Pleasant Prairie WI, US Brian S. Brown - Evanston IL, US Wilfried Braje - Mannheim, DE Michael Curtin - Pleasant Prairie WI, US Howard Robin Heyman - Deerfield IL, US Victoria Scott - Libertyville IL, US Karen Kage - Chicago IL, US Steven Cassar - Kenosha WI, US Anil Vasudevan - Union Grove WI, US
Compounds having the formula:are useful for inhibiting protein kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
Cholinergic/Serotoninergic Receptor And Uses Thereof
Murali Gopalakrishnan - Libertyville IL, US Jinhe Li - Long Grove IL, US Steven C. Cassar - Kenosha WI, US John Malysz - Columbia SC, US David J. Anderson - Lake Bluff IL, US Earl J. Gubbins - Libertyville IL, US Daniel C. Bertrand - Geneva, CH
The present invention describes new cholinergic/serotoninergic chimeric receptors and provides methods and compositions suitable for screening for ligands such as agonists, antagonists and allosteric modulators of α7 nicotinic acetylcholine receptors.
Cholinergic/Serotoninergic Receptor And Uses Thereof
Murali Gopalakrishnan - Libertyville IL, US Jinhe Li - Long Grove IL, US Steven C. Cassar - Kenosha WI, US John Malysz - Round Lake IL, US David J. Anderson - Lake Bluff IL, US Earl J. Gubbins - Libertyville IL, US Daniel C. Bertrand - Geneva, CH
The present invention describes new cholinergic/serotoninergic chimeric receptors and provides methods and compositions suitable for screening for ligands such as agonists, antagonists and allosteric modulators of α7 nicotinic acetylcholine receptors.